Potassium iodide tablets

This product is an iodine supplement. Potassium iodide can have two effects on thyroid function depending on the dosage. 1. When preventing and treating endemic (simple) goiter, a small dose of iodine preparation is given as a raw material for iodine to synthesize thyroxine, correct the original excessive secretion of pituitary thyrotropin, and shrink the enlarged thyroid gland. 2. Large doses of iodine are used as antithyroid drugs to temporarily control hyperthyroidism. This may be achieved by inhibiting thyroglobulin hydrolase, preventing the release of free thyroid hormone into the blood, and the effect is fast and strong, but not lasting. It temporarily inhibits the synthesis of thyroid hormones, and the inhibitory effect may disappear after continuous administration, resulting in more severe hyperthyroidism symptoms. Therefore, it is only used for thyroid crisis to quickly improve symptoms, and must be used in conjunction with thiourea.

Potassium iodide

This product is a white tablet.

Prevention and treatment of endemic goiter, preoperative preparation for hyperthyroidism and hyperthyroid crisis.

1. Prevention of endemic goiter: The dosage is determined according to the local iodine deficiency, generally 100μg/day is sufficient. 2. Treatment of endemic goiter: For early stage patients, 1-10mg/day is given for 1-3 months, with a 30-40 day break. After about 1-2 months, the dosage can be gradually increased to 20-25mg/day, and the total course of treatment is about 3-6 months.

1 Allergic reaction, which is uncommon. Angioedema may occur immediately after taking the medicine, or several hours later, manifested as edema of the upper limbs, lower limbs, face, lips, tongue or throat, and may also cause skin erythema or wheals, fever, and discomfort. 2 Joint pain, eosinophilia, and lymphadenopathy, which are uncommon. 3 Long-term use may cause symptoms of iodine poisoning such as burning sensation in the mouth and throat, salivation, metallic taste, gum pain, stomach discomfort, and severe headache; hyperkalemia may also occur, manifested as confusion, arrhythmia, numbness and tingling in the hands and feet, and heaviness and weakness in the lower limbs. 4 Digestive adverse reactions such as diarrhea, nausea, vomiting, and stomach pain are uncommon. 5

1. Iodide can pass through the placenta, causing abnormal thyroid function and/or thyroid enlargement in the fetus, so it is strictly forbidden for pregnant women to use it. 2. Iodide can be secreted into breast milk, which can easily cause rashes in infants and suppress thyroid function, so women should not use it or stop breastfeeding during breastfeeding. 3. Iodine solution can easily cause rashes in infants and young children, affecting thyroid function, so it should be forbidden.

Precautions for children: Infants and young children may develop rashes when using iodine solution, which may affect thyroid function and should be prohibited from use. Precautions for pregnancy and lactation: (1) Iodide can pass through the placenta and cause abnormal thyroid function and/or thyroid enlargement in the fetus. Pregnant women are strictly prohibited from using it. (2) Iodide can be secreted into breast milk. Breastfeeding can easily cause rashes in infants and suppress thyroid function. Therefore, breastfeeding should be prohibited or stopped during breastfeeding. Precautions for the elderly: This product has not been tested and there is no reliable reference literature.

1. When used in combination with antithyroid drugs, it may cause hypothyroidism and goiter. 2. When used in combination with angiotensin-converting enzyme inhibitors or potassium-sparing diuretics, it is easy to cause hyperkalemia, and blood potassium should be monitored. 3. When used in combination with lithium salts, it may cause hypothyroidism and goiter. 4. When used in combination with 131I, it will reduce the uptake of 131I by thyroid tissue.

Keep away from light, seal tightly and store in a dry place.

10mg

18 months

Xiuzheng Pharmaceutical Group Co., Ltd.

• Founded in:

  1999-03-29

• Address:

  No. 36, Zhengxiu Road, Tonghua City, Jilin Province

• Tax NO.:

  91220501244585084W

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view